Events Partner Content 3rd Annual Medical Device Project and Portfolio Management This two-day event guarantees top notch networking
Events Partner Content World Drug Safety Congress Returns to Philadelphia April 10-... Proactive Safety, Minimizing Risk.
Events Partner Content ePharma | Accelerate Your Digital Strategy to Create Meaning... Accelerate Your Digital Strategy
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
